Ramiro Guerrero, Director at MAIA Biotechnology, Inc. (MAIA), bought 1,263 shares at $4.17 ($5K) on 2023-04-18, disclosed to the SEC on 2023-04-19.
Scheduled purchase ($5k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MAIA | BUY | 2026-08-26 | $2K | — | Filing → |
| MAIA | BUY | 2026-08-24 | $16K | — | Filing → |
| MAIA | BUY | 2025-05-12 | $30K | — | Filing → |